Author:
Dubin Ruth,Cushman Mary,Folsom Aaron R,Fried Linda F,Palmas Walter,Peralta Carmen A,Wassel Christina,Shlipak Michael G
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. KDOQI: Definition and Classification of Stages of Chronic Kidney Disease. 2002, [ http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p4_class_g2.htm ]
2. Coresh J, Astor B, Sarnak MJ: Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2004, 13 (1): 73-81.
3. Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007, 116 (1): 85-97.
4. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, et al: Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006, 145 (4): 237-46.
5. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005, 352 (20): 2049-60.
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献